(Q84616024)

English

Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15

scientific article published on 01 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

W. Gong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

W. Xiao

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

M. Hu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

X. Weng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

L. Qian

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

X. Pan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

M. Ji

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670353

13 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20670353

13 June 2024

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-0039.2010.01535.x

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0039.2010.01535.x/fullpdf

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Tissue Antigens

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

467-475

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Functions of natural killer cells

1

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

NKG2D ligands in tumor immunity

2

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

3

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

NK cell recognition

4

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

A second lineage of mammalian major histocompatibility complex class I genes

5

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

6

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

7

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

8

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Establishment and characterization of a cell based artificial antigen-presenting cell for expansion and activation of CD8+ T cells ex vivo

9

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

10

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

IL-15/IL-15 receptor biology: a guided tour through an expanding universe

11

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Expansion of highly cytotoxic human natural killer cells for cancer cell therapy

12

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

13

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

14

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Unexpected partnership between IL-15 and DAP10

15

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway

16

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

17

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

CD107a as a functional marker for the identification of natural killer cell activity.

18

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity

19

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction

20

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

21

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

22

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

23

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

24

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

25

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation

26

1 reference

10.1111/J.1399-0039.2010.01535.X

https://api.crossref.org/works/10.1111/J.1399-0039.2010.01535.X

13 June 2024

Identifiers

10.1111/J.1399-0039.2010.01535.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670353%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84616024&oldid=2178113482"